2024 U.S. Hepatitis Diagnostic Testing for 10 Markers: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for Immunodiagnostic and Molecular Diagnostic Procedures--Hospitals, Blood Banks, Commercial Labs, POC Locations
The report presents a detailed analysis of the Hepatitis diagnostics market in the US. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides five-year test volume and sales forecasts for HAV NAT, HBV NAT, HBs Ag, HCV, Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag, HBe Ag, and ALT/SGPT tests performed in the following markets:
I. Introduction
II. Hepatitis Worldwide Market and Technology Overview
A. Background
B. Hepatitis A
C. Hepatitis B
D. Hepatitis C
0 CLASSIFICATION
0 TRANSMISSION OF INFECTION
0 OCCUPATIONAL HAZARDS
0 ACUTE HEPATITIS
0 DIAGNOSIS OF ACUTE INFECTION
0 CHRONIC HEPATITIS
0 HCV AND OTHER CHRONIC LIVER DISEASES
0 ALCOHOLIC LIVER DISEASE
0 HEPATITIS B COINFECTION
0 CIRRHOSIS AND HEPATOCELLULAR CARCINOMA
0 DIAGNOSTIC TESTS
0 POSSIBLE INDICATIONS FOR HCV RNA TESTING
0 CONCLUSIONS AND FUTURE DIRECTION
E. Hepatitis D
0 HISTORICAL PERSPECTIVE
0 EPIDEMIOLOGY
0 HBV-HDV COINFECTION VS. SUPERINFECTION
0 METHODS OF DETECTING HDV
0 PREVENTION
F. Hepatitis E
0 BACKGROUND
0 PREVALENCE OF THE DISEASE
0 DIAGNOSTIC TESTS
0 EPIDEMIOLOGIC SEROSURVEYS
0 SEROLOGIC CROSS-REACTIVITY
G. Hepatitis G
0 VACCINES AND DRUGS
H. Review of Leading Analyzers Marketed by: Abbott, Beckman
Coulter/Danaher, BioMerieux, Ortho-Clinical Diagnostics, Roche,
Siemens, Tosoh, Wallac and Other Suppliers
I. Emerging Diagnostic Technologies
1. MOLECULAR DIAGNOSTICS
2. MONOCLONAL ANTIBODIES
3. IMMUNOASSAYS
4. DIFFERENTIAL LIGHT SCATTERING
5. INFORMATION TECHNOLOGY
6. ARTIFICIAL INTELLIGENCE
7. LIPOSOMES
8. FLOW CYTOMETRY
9. CHROMATOGRAPHY
10. DIAGNOSTIC IMAGING
11. GEL MICRODROPLETS
12. OTHER
III. USA: Market Size, Growth and Major Suppliers’
Sales and Market Shares
X. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
1. MARKETING APPROACHES
2. PRODUCT COMPLEXITY
3. CUSTOMER PREFERENCE
4. ESTABLISHED SUPPLIERS
5. EMERGING SUPPLIERS
6. MAJOR TYPES OF DISTRIBUTORS
7. MARKET SEGMENTATION
II. Hepatitis Worldwide Market and Technology Overview
A. Background
B. Hepatitis A
C. Hepatitis B
D. Hepatitis C
0 CLASSIFICATION
0 TRANSMISSION OF INFECTION
0 OCCUPATIONAL HAZARDS
0 ACUTE HEPATITIS
0 DIAGNOSIS OF ACUTE INFECTION
0 CHRONIC HEPATITIS
0 HCV AND OTHER CHRONIC LIVER DISEASES
0 ALCOHOLIC LIVER DISEASE
0 HEPATITIS B COINFECTION
0 CIRRHOSIS AND HEPATOCELLULAR CARCINOMA
0 DIAGNOSTIC TESTS
0 POSSIBLE INDICATIONS FOR HCV RNA TESTING
0 CONCLUSIONS AND FUTURE DIRECTION
E. Hepatitis D
0 HISTORICAL PERSPECTIVE
0 EPIDEMIOLOGY
0 HBV-HDV COINFECTION VS. SUPERINFECTION
0 METHODS OF DETECTING HDV
0 PREVENTION
F. Hepatitis E
0 BACKGROUND
0 PREVALENCE OF THE DISEASE
0 DIAGNOSTIC TESTS
0 EPIDEMIOLOGIC SEROSURVEYS
0 SEROLOGIC CROSS-REACTIVITY
G. Hepatitis G
0 VACCINES AND DRUGS
H. Review of Leading Analyzers Marketed by: Abbott, Beckman
Coulter/Danaher, BioMerieux, Ortho-Clinical Diagnostics, Roche,
Siemens, Tosoh, Wallac and Other Suppliers
I. Emerging Diagnostic Technologies
1. MOLECULAR DIAGNOSTICS
2. MONOCLONAL ANTIBODIES
3. IMMUNOASSAYS
4. DIFFERENTIAL LIGHT SCATTERING
5. INFORMATION TECHNOLOGY
6. ARTIFICIAL INTELLIGENCE
7. LIPOSOMES
8. FLOW CYTOMETRY
9. CHROMATOGRAPHY
10. DIAGNOSTIC IMAGING
11. GEL MICRODROPLETS
12. OTHER
III. USA: Market Size, Growth and Major Suppliers’
Sales and Market Shares
X. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
1. MARKETING APPROACHES
2. PRODUCT COMPLEXITY
3. CUSTOMER PREFERENCE
4. ESTABLISHED SUPPLIERS
5. EMERGING SUPPLIERS
6. MAJOR TYPES OF DISTRIBUTORS
7. MARKET SEGMENTATION